Delivery Order SPE2DB20D2104-SPE2DB24FS58Q
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Oseltamivir 6 mg/mL suspension in 60 mL bottles. The fixed-price contract has a ceiling value of $2,005.05 and an ultimate completion date of November 4, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award, valued at $1,021.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oseltamivir 6 mg/ml suspension (60 ml) and has a completion date of November 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that serves as a critical supplier of pharmaceutical products and medical supplies to...
- The Defense Logistics Agency awarded a $1,084.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Oseltamivir 6 mg/mL suspension in 60 mL quantities. This is a non-set-aside competitive award with performance to be completed by January 16, 2026, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of Oseltamivir Phosphate 75mg capsules. The $1,359.87 firm-fixed-price contract has an ultimate completion date of December 5, 2023. This order is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- The Defense Logistics Agency awarded a delivery order valued at $1,513.44 to AmerisourceBergen Drug Corp for the supply of Oseltamivir 6 mg/ml suspension in 60ml quantities. This competitive, firm fixed-price delivery order, issued on January 22, 2026, is set to be completed by January 23, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the provision of Oseltamivir Phosphate 75 mg capsules. The contract has a ceiling value of $1,434.74 and a period of performance through March 11, 2024. This is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that supplies a wide range of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Oseltamivir 6 mg/ml suspension in 60 ml quantities, with a contract ceiling value of $1,564.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 23, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a $2,368.80 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Oseltamivir 6 mg/ml suspension in 60ml quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of oseltamivir 6 mg/ml suspension in 60 ml bottles. The contract has a ceiling value of $4,635.43 and is a firm fixed price arrangement. The award is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir 6 mg/ml Suspension in 60ml quantities, valued at $1,055.36. This is a firm fixed price delivery order with no set-aside designation, executed on September 19, 2025, with an ultimate completion date of September 22, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS58QDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Oseltamivir 6 mg/mL suspension in 60 mL bottles. The firm-fixed-price contract has a ceiling value of $2,464.53 and runs through February 15, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare globally. This delivery order is likely part of that broader IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 2/14/24 |